182 related articles for article (PubMed ID: 31948534)
21. Evaluation of tripartite motif 59 and its diagnostic utility in benign bowel diseases and colorectal cancer.
Dahpy MA; Salama RHM; Kamal AA; El-Deek HE; AbdelMotaleb AA; Abd-El-Rehim AS; Hassan EA; Alsanory AA; Saad MM; Ali M
J Biochem Mol Toxicol; 2022 Jul; 36(7):e23065. PubMed ID: 35377964
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
Gharabaghi MA
Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
[TBL] [Abstract][Full Text] [Related]
24. Small ubiquitin-like modifier/sentrin-specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non-small cell lung cancer.
Liu K; Zhang J; Wang H
J Clin Lab Anal; 2018 Nov; 32(9):e22611. PubMed ID: 30043429
[TBL] [Abstract][Full Text] [Related]
25. Tripartite motif containing 59 (TRIM59) promotes esophageal cancer progression via promoting MST4 expression and ERK pathway.
Liu G; Song J; Zhao Y; Zhang L; Qin J; Cui Y
J Recept Signal Transduct Res; 2020 Oct; 40(5):471-478. PubMed ID: 32340525
[No Abstract] [Full Text] [Related]
26. [Hsp90AB1 Protein is Overexpressed in Non-small Cell Lung Cancer Tissues
and Associated with Poor Prognosis in Lung Adenocarcinoma Patients].
Wang M; Feng L; Li P; Han N; Gao Y; Xiao T
Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):64-9. PubMed ID: 26903158
[TBL] [Abstract][Full Text] [Related]
27. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway.
Wu C; Shang XQ; You ZP; Jin QF; Zhang YL; Zhou Y; Zhang YZ; Shi K
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):2. PubMed ID: 32744597
[TBL] [Abstract][Full Text] [Related]
28. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma.
Piao L; Yang Z; Feng Y; Zhang C; Cui C; Xuan Y
BMC Cancer; 2019 Sep; 19(1):898. PubMed ID: 31500591
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59.
Cheng H; Chen L; Hu X; Qiu H; Xu X; Gao L; Tang G; Zhang W; Wang J; Yang J; Huang C
J Cell Physiol; 2019 Apr; 234(4):5186-5195. PubMed ID: 30370525
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
Fujita Y; Fujikane T; Fujiuchi S; Nishigaki Y; Yamazaki Y; Nagase A; Shimizu T; Ohsaki Y; Kikuchi K
Cancer; 2003 Sep; 98(5):1008-13. PubMed ID: 12942569
[TBL] [Abstract][Full Text] [Related]
31. MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.
Sun L; Yuan H; Burnett J; Gasparyan M; Zhang Y; Zhang F; Yang Z; Ran Y; Sun D
Int J Med Sci; 2019; 16(1):68-74. PubMed ID: 30662330
[No Abstract] [Full Text] [Related]
32. MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer.
Yuan K; Chen Z; Li W; Gao CE; Li G; Guo G; Yang Y; Ai Y; Wu L; Zhang M
Arch Med Res; 2015 Nov; 46(8):635-41. PubMed ID: 26656665
[TBL] [Abstract][Full Text] [Related]
33. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract][Full Text] [Related]
34. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
[TBL] [Abstract][Full Text] [Related]
35. [Expression of NUSAP1 and its relationship with prognosis in non-small cell lung cancer].
Yu Z; Li XM; Huai M; Cao SS; Han HY; Liu HT
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):522-526. PubMed ID: 31357839
[No Abstract] [Full Text] [Related]
36. [Prognostic value of MACC1 and c-met expressions in non-small cell lung cancer].
Hu X; Fu X; Wen S; Zou X; Liu Y
Zhongguo Fei Ai Za Zhi; 2012 Jul; 15(7):399-403. PubMed ID: 22814258
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of long non-coding RNA SNHG16 correlates with tumor progression and poor prognosis in non-small cell lung cancer.
Han W; Du X; Liu M; Wang J; Sun L; Li Y
Int J Biol Macromol; 2019 Jan; 121():270-278. PubMed ID: 30287374
[TBL] [Abstract][Full Text] [Related]
38. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
[TBL] [Abstract][Full Text] [Related]
39. Neuroepithelial transforming gene 1 functions as a potential prognostic marker for patients with non-small cell lung cancer.
Fang L; Zhu J; Ma Y; Hong C; Xiao S; Jin L
Mol Med Rep; 2015 Nov; 12(5):7439-46. PubMed ID: 26459749
[TBL] [Abstract][Full Text] [Related]
40. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer.
Li W; Cui Y; Wang D; Wang Y; Wang L
Biochem Biophys Res Commun; 2019 Feb; 509(3):647-656. PubMed ID: 30611568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]